ZIMMER BIOMET HOLDINGS, INC. Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax
ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax of $24.30 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Summary of Derivative Instruments
us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax · last filed 2026-08-05
- ZIMMER BIOMET HOLDINGS, INC. gain (loss) on derivative used in net investment hedge, after tax for the quarter ending 2026-06-30 was $24.30M.
- ZIMMER BIOMET HOLDINGS, INC. gain (loss) on derivative used in net investment hedge, after tax for the quarter ending 2026-03-31 was $51.60M.
- ZIMMER BIOMET HOLDINGS, INC. gain (loss) on derivative used in net investment hedge, after tax for the quarter ending 2025-12-31 was $19.50M, a 88.34% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. gain (loss) on derivative used in net investment hedge, after tax for the quarter ending 2025-09-30 was -$4.30M.
- ZIMMER BIOMET HOLDINGS, INC. gain (loss) on derivative used in net investment hedge, after tax for fiscal 2025 was -$271.80M, a 269.56% decline from fiscal 2024.
- ZIMMER BIOMET HOLDINGS, INC. gain (loss) on derivative used in net investment hedge, after tax for fiscal 2024 was $160.30M.
- ZIMMER BIOMET HOLDINGS, INC. gain (loss) on derivative used in net investment hedge, after tax for fiscal 2023 was -$54.30M, a 145.44% decline from fiscal 2022.
- ZIMMER BIOMET HOLDINGS, INC. gain (loss) on derivative used in net investment hedge, after tax for fiscal 2022 was $119.50M.
| Period end | Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax 3 month | Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax 6 month | Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax 9 month | Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $24.30M 10-Q · filed 2026-08-05 | $75.90M 10-Q · filed 2026-08-05 | $95.40M derived: sum of 3 quarters · filed 2026-08-05 | $91.10M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $51.60M 10-Q · filed 2026-05-01 | $71.10M derived: sum of 2 quarters · filed 2026-05-01 | $66.80M derived: sum of 3 quarters · filed 2026-05-01 | -$121.80M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $19.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $15.20M derived: sum of 2 quarters · filed 2026-02-20 | -$173.40M derived: sum of 3 quarters · filed 2026-08-05 | -$271.80M 10-K · filed 2026-02-20 |
| 2025-09-30 | -$4.30M 10-Q · filed 2025-11-05 | -$192.90M derived: sum of 2 quarters · filed 2026-08-05 | -$291.30M 10-Q · filed 2025-11-05 | -$123.90M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$188.60M 10-Q · filed 2026-08-05 | -$286.90M 10-Q · filed 2026-08-05 | -$119.60M derived: sum of 3 quarters · filed 2026-08-05 | -$230.80M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$98.30M 10-Q · filed 2026-05-01 | $69.00M derived: sum of 2 quarters · filed 2026-05-01 | -$42.20M derived: sum of 3 quarters · filed 2026-05-01 | -$8.40M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $167.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $56.10M derived: sum of 2 quarters · filed 2026-02-20 | $89.90M derived: sum of 3 quarters · filed 2026-02-20 | $160.30M 10-K · filed 2026-02-20 |
| 2024-09-30 | -$111.20M 10-Q · filed 2025-11-05 | -$77.40M derived: sum of 2 quarters · filed 2025-11-05 | -$7.00M 10-Q · filed 2025-11-05 | -$105.80M derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-06-30 | $33.80M 10-Q · filed 2025-08-07 | $104.30M 10-Q · filed 2025-08-07 | $5.40M derived: sum of 3 quarters · filed 2026-02-20 | $70.10M derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-03-31 | $70.50M 10-Q · filed 2025-05-05 | -$28.40M derived: sum of 2 quarters · filed 2026-02-20 | $36.30M derived: sum of 3 quarters · filed 2026-02-20 | $39.90M derived: sum of 4 quarters · filed 2026-02-20 |
| 2023-12-31 | -$98.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | -$34.20M derived: sum of 2 quarters · filed 2026-02-20 | -$30.60M derived: sum of 3 quarters · filed 2026-02-20 | -$54.30M 10-K · filed 2026-02-20 |
| 2023-09-30 | $64.70M 10-Q · filed 2024-10-30 | $68.30M derived: sum of 2 quarters · filed 2024-10-30 | $44.60M 10-Q · filed 2024-10-30 | -$148.30M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $3.60M 10-Q · filed 2024-08-07 | -$20.10M 10-Q · filed 2024-08-07 | -$213.00M derived: sum of 3 quarters · filed 2025-02-25 | -$90.00M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | -$23.70M 10-Q · filed 2024-05-02 | -$216.60M derived: sum of 2 quarters · filed 2025-02-25 | -$93.60M derived: sum of 3 quarters · filed 2025-02-25 | $46.60M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | -$192.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$69.90M derived: sum of 2 quarters · filed 2025-02-25 | $70.30M derived: sum of 3 quarters · filed 2025-02-25 | $119.50M 10-K · filed 2025-02-25 |
| 2022-09-30 | $123.00M 10-Q · filed 2023-11-07 | $263.20M derived: sum of 2 quarters · filed 2023-11-07 | $312.40M 10-Q · filed 2023-11-07 | $394.10M derived: sum of 4 quarters · filed 2024-08-07 |
| 2022-06-30 | $140.20M 10-Q · filed 2023-08-01 | $189.40M 10-Q · filed 2023-08-01 | $271.10M derived: sum of 3 quarters · filed 2024-08-07 | $328.00M derived: sum of 4 quarters · filed 2024-08-07 |
| 2022-03-31 | $49.20M 10-Q · filed 2023-05-02 | $130.90M derived: sum of 2 quarters · filed 2024-08-07 | $187.80M derived: sum of 3 quarters · filed 2024-08-07 | $143.80M derived: sum of 4 quarters · filed 2024-08-07 |
| 2021-12-31 | $81.70M derived: 8-K 12 month − 10-Q 9 month · filed 2024-08-07 | $138.60M derived: sum of 2 quarters · filed 2024-08-07 | $94.60M derived: sum of 3 quarters · filed 2024-08-07 | $232.60M 8-K · filed 2024-08-07 |
| 2021-09-30 | $56.90M 10-Q · filed 2022-11-02 | $12.90M derived: sum of 2 quarters · filed 2022-11-02 | $150.90M 10-Q · filed 2022-11-02 | -$13.50M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-06-30 | -$44.00M 10-Q · filed 2022-08-02 | $93.90M 10-Q · filed 2022-08-02 | -$70.40M derived: sum of 3 quarters · filed 2023-02-24 | -$228.60M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-03-31 | $137.90M 10-Q · filed 2022-05-05 | -$26.40M derived: sum of 2 quarters · filed 2023-02-24 | -$184.60M derived: sum of 3 quarters · filed 2023-02-24 | -$265.20M derived: sum of 4 quarters · filed 2023-02-24 |
| 2020-12-31 | -$164.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | -$322.50M derived: sum of 2 quarters · filed 2023-02-24 | -$403.10M derived: sum of 3 quarters · filed 2023-02-24 | -$295.30M 10-K · filed 2023-02-24 |
| 2020-09-30 | -$158.20M 10-Q · filed 2021-11-04 | -$238.80M derived: sum of 2 quarters · filed 2021-11-04 | -$131.00M 10-Q · filed 2021-11-04 | -$220.20M derived: sum of 4 quarters · filed 2022-06-22 |
| 2020-06-30 | -$80.60M 10-Q · filed 2021-08-03 | $27.20M 10-Q · filed 2021-08-03 | -$62.00M derived: sum of 3 quarters · filed 2022-06-22 | $62.20M derived: sum of 4 quarters · filed 2022-06-22 |
| 2020-03-31 | $107.80M 10-Q · filed 2021-05-04 | $18.60M derived: sum of 2 quarters · filed 2022-06-22 | $142.80M derived: sum of 3 quarters · filed 2022-06-22 | $111.80M derived: sum of 4 quarters · filed 2022-06-22 |
| 2019-12-31 | -$89.20M derived: 8-K 12 month − 10-Q 9 month · filed 2022-06-22 | $35.00M derived: sum of 2 quarters · filed 2022-06-22 | $4.00M derived: sum of 3 quarters · filed 2022-06-22 | $58.60M 8-K · filed 2022-06-22 |
| 2019-09-30 | $124.20M 10-Q · filed 2020-11-06 | $93.20M derived: sum of 2 quarters · filed 2020-11-06 | $147.80M 10-Q · filed 2020-11-06 | $201.50M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-06-30 | -$31.00M 10-Q · filed 2020-08-05 | $23.60M 10-Q · filed 2020-08-05 | $77.30M derived: sum of 3 quarters · filed 2021-02-22 | $79.40M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-03-31 | $54.60M 10-Q · filed 2020-05-11 | $108.30M derived: sum of 2 quarters · filed 2021-02-22 | $110.40M derived: sum of 3 quarters · filed 2021-02-22 | $201.50M derived: sum of 4 quarters · filed 2021-02-22 |
| 2018-12-31 | $53.70M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $55.80M derived: sum of 2 quarters · filed 2021-02-22 | $146.90M derived: sum of 3 quarters · filed 2021-02-22 | $120.40M 10-K · filed 2021-02-22 |
| 2018-09-30 | $2.10M 10-Q · filed 2019-11-05 | $93.20M derived: sum of 2 quarters · filed 2019-11-05 | $66.70M 10-Q · filed 2019-11-05 | $48.20M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-06-30 | $91.10M 10-Q · filed 2019-08-05 | $64.70M 10-Q · filed 2019-08-05 | $46.10M derived: sum of 3 quarters · filed 2020-02-21 | $4.40M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-03-31 | -$26.50M 10-Q · filed 2019-05-06 | -$45.00M derived: sum of 2 quarters · filed 2020-02-21 | -$86.70M derived: sum of 3 quarters · filed 2020-02-21 | -$157.70M derived: sum of 4 quarters · filed 2020-02-21 |
| 2017-12-31 | -$18.50M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | -$60.20M derived: sum of 2 quarters · filed 2020-02-21 | -$131.20M derived: sum of 3 quarters · filed 2020-02-21 | -$146.00M 10-K · filed 2020-02-21 |
| 2017-09-30 | -$41.70M 10-Q · filed 2018-11-01 | -$112.70M derived: sum of 2 quarters · filed 2018-11-01 | -$127.50M 10-Q · filed 2018-11-01 | |
| 2017-06-30 | -$71.00M 10-Q · filed 2018-08-06 | -$85.80M 10-Q · filed 2018-08-06 | ||
| 2017-03-31 | -$14.80M 10-Q · filed 2018-05-08 | |||
| 2016-12-31 | $18.80M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |